By shifting the PFKFB3/G6PD ratio, the T-cells in patients with RA skew glucose metabolism from ATP production towards NADPH biosynthesis, which generates inflammation-inducing effector cells [9]. This evidence concerns the gene G6PD and rheumatoid arthritis.